The antiviral drug Paxlovid reduces the risk of getting long COVID
Why treating Covid-19 with drugs is harder than you think - BBC Future
The Antivirals are Coming! | Office for Science and Society - McGill University
Could a popular COVID-19 antiviral supercharge the pandemic? | Science | AAAS
As U.S. COVID-19 cases rise, so does demand for antivirals | Reuters
Could oral antiviral pills be a game-changer for COVID-19? An infectious disease physician explains why these options are badly needed
How to Discover Antiviral Drugs Quickly | NEJM
Australians over 70 granted access to Covid antiviral treatments | Health | The Guardian
US warns monkeypox could mutate to resist antiviral drug | AP News
Calls to expand access to Covid antivirals in Australia splits experts and doctors | Health | The Guardian
Antiviral drug - Wikipedia
Community Eye Health Journal » Overview of antiviral medications used in ophthalmology
Italy to receive 40,000 Merck antiviral drug doses next week - official | Reuters
How antiviral medication stops viruses in their tracks | Edward-Elmhurst Health
New Antiviral Drug Combination Is Highly Effective Against SARS-CoV-2, Penn Study Finds - Penn Medicine
How antiviral pill molnupiravir shot ahead in the COVID drug hunt
Covid-19 antivirals surge forward | Business | Chemistry World
Antiviral Pills Like Paxlovid Help Treat Covid. Here's How to Get Them. - The New York Times
Thousands needed to try a new Covid antiviral treatment - BBC News
Oral Antiviral Matches Paxlovid in High-Risk COVID | MedPage Today
Center for Translational Antiviral Research Reports Novel Broad-Spectrum Antiviral Drug Class with Activity Against SARS-CoV-2 - Next Generation Program
Pharmac criticised over delayed delivery of antiviral drug to treat Covid-19 | RNZ News
Paxlovid May Reduce Risk of Long Covid in Eligible Patients, Study Finds - The New York Times
Merck's new COVID drug molnupiravir gets FDA consideration : Shots - Health News : NPR
RACGP - COVID-19 antiviral pills to be reserved primarily for the unvaccinated
COVID-19 antivirals – your questions answered | NSW Government
Antiviral drug discovery – Part 3: When the virus fights back – antiviral resistance | VIROLOGY RESEARCH SERVICES
